chr19:46850344:> Detail (hg19)
Information
Genome
Assembly | Position |
---|---|
hg19 | chr19:46,850,344-46,894,232 |
hg38 | chr19:46,347,087-46,390,975 |
HGVS
Type | Transcript | Protein |
---|---|---|
Summary
MGeND
Clinical significance | |
Variant entry | |
GWAS entry | |
Disease area statistics | Show details |
Frequency
[No Data.]
Prediction
[No Data.]
ClinVar
Clinical Significance | |
Review star | [No Data.] |
Show details |
Links
Disease area statistics
[No Data.]
MGeND
[No Data.]
ClinVar
[No Data.]
CIViC
[No Data.]
DisGeNET
Score | Disease name | Description | Source | Pubmed | Links |
---|---|---|---|---|---|
0.120 | Crohn Disease | NA | GWASCAT | Detail | |
<0.001 | Pain in lower limb | Patients with the CT/TT genotype reported a higher VAS leg pain intensity (P=0.0... | BeFree | 24300227 | Detail |
<0.001 | leukemia | However, these levels decreased when IGF-IR was inhibited by addition of PPP. v)... | BeFree | 25095896 | Detail |
<0.001 | Neuronal Ceroid-Lipofuscinoses | NA | BeFree | Detail | |
<0.001 | Pain | The primary outcome measures were pain intensity scores for the lower back and l... | BeFree | 24300227 | Detail |
<0.001 | thyroiditis | NA | BeFree | Detail | |
<0.001 | Pancreatitis, Chronic | NA | BeFree | Detail | |
<0.001 | Left Ventricular Hypertrophy | NA | BeFree | Detail | |
<0.001 | Tumor Progression | Ser/Thr protein phosphatase 5 (PPP5C) has been reported to participate in tumor ... | BeFree | 25326185 | Detail |
<0.001 | teratocarcinoma | NA | BeFree | Detail | |
<0.001 | Infantile neuronal ceroid lipofuscinosis | NA | BeFree | Detail | |
0.001 | Malignant neoplasm of prostate | In conclusion, Ad-PL-PPT-E1A exhibited enhanced antitumor activity is a promisin... | BeFree | 24849040 | Detail |
<0.001 | Carcinogenesis | NA | BeFree | Detail | |
0.001 | prostate carcinoma | In conclusion, Ad-PL-PPT-E1A exhibited enhanced antitumor activity is a promisin... | BeFree | 24849040 | Detail |
0.003 | Mammary Neoplasms | NA | LHGDN | Detail | |
<0.001 | liver carcinoma | Knockdown of PPP5C inhibits growth of hepatocellular carcinoma cells in vitro. | BeFree | 25326185 | Detail |
<0.001 | Ceroid lipofuscinosis, neuronal 1, infantile | NA | BeFree | Detail | |
<0.001 | bipolar disorder | NA | BeFree | Detail | |
<0.001 | Adenocarcinoma of prostate | NA | BeFree | Detail |
Annotation
Annotations
Descrption | Source | Links |
---|---|---|
NA | DisGeNET | Detail |
Patients with the CT/TT genotype reported a higher VAS leg pain intensity (P=0.002) and also a lower... | DisGeNET | Detail |
However, these levels decreased when IGF-IR was inhibited by addition of PPP. v) Co-culture of the d... | DisGeNET | Detail |
NA | DisGeNET | Detail |
The primary outcome measures were pain intensity scores for the lower back and legs using a visual a... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Ser/Thr protein phosphatase 5 (PPP5C) has been reported to participate in tumor progression. | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
In conclusion, Ad-PL-PPT-E1A exhibited enhanced antitumor activity is a promising approach for gene ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
In conclusion, Ad-PL-PPT-E1A exhibited enhanced antitumor activity is a promising approach for gene ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Knockdown of PPP5C inhibits growth of hepatocellular carcinoma cells in vitro. | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Overlapped Transcript Coordinates
Gene | Transcript ID | Exon Number | Chromosome | Start | Stop | Type | Amino Mutation | Transcript Position | Links |
---|
Overlapped Transcript
Gene | Transcript ID | Chromosome | Start | Stop | Links |
---|
- Gene
- -
- Genome
- hg19
- Position
- chr19:46,850,344-46,894,232
- Variant Type
- snv
Genome browser